rotigotine

FDA Drug Profile — Neupro

Drug Details

Generic Name
rotigotine
Brand Names
Neupro
Application Number
NDA021829
Sponsor
UCB, Inc.
NDC Codes
8
Dosage Forms
KIT, PATCH, EXTENDED RELEASE, POWDER
Routes
TRANSDERMAL
Active Ingredients
ROTIGOTINE

Indications and Usage

1 INDICATIONS AND USAGE NEUPRO is a dopamine agonist indicated for the treatment of: Parkinson's disease ( 1.1 ) Moderate-to-severe primary Restless Legs Syndrome ( 1.2 ) 1.1 Parkinson's Disease (PD) NEUPRO is indicated for the treatment of Parkinson's disease. 1.2 Restless Legs Syndrome (RLS) NEUPRO is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome.